China In-Vitro Diagnostics Market is predicted to reach USD 17.24 Billion by 2030

According to the study by Next Move Strategy Consulting, the China In-Vitro Diagnostics Market size is predicted to reach USD 17.24 billion, at a CAGR of 4.1% by 2030.

Request a FREE Sample: https://www.nextmsc.com/china-in-vitro-diagnostics-market/request-sample

The prevalence of chronic diseases significantly drives the growth of the in-vitro diagnostics market in China.

The extensive healthcare infrastructure in the country serves as a pivotal driver for the China in-vitro diagnostics market growth.

The promising players operating in the China in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.